Security key
09627Y109
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)
CUSIP: 09627Y109
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 65,000,000
- Total 13F shares
- 56,891,234
- Share change
- +1,085,390
- Total reported value
- $5,271,748,149
- Put/Call ratio
- 90%
- Price per share
- $92.70
- Number of holders
- 233
- Value change
- +$134,477,194
- Number of buys
- 106
- Number of sells
- 104
Report period
Q3 2020
Institutions
233
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 09627Y109
Recent filing periods:
Top shareholders of BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2020
As of 30 Sep 2020,
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,891,234 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, CADIAN CAPITAL MANAGEMENT, LP, STATE STREET CORP, Casdin Capital, LLC, VIKING GLOBAL INVESTORS LP, JPMORGAN CHASE & CO, and HILLHOUSE CAPITAL ADVISORS, LTD..
This page lists
233
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
227
Q3 2020 holders
233
Holder diff
6
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.